Cytochromes P450 as promising catalysts for biotechnological application: Chances and limitations

Applied Microbiology and Biotechnology

Volumn 98, Issue 14, 2014, Pages 6185-6203

  Bernhardt, Rita ^a   Urlacher, Vlada B ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biotechnology; Biotransformation; Cytochrome P450; De novo biosynthesis; Electron transfer; Redox partners

Indexed keywords

BIOCHEMISTRY; CATALYSTS; ELECTRON TRANSITIONS; ENZYMES;

BIOTECHNOLOGICAL APPLICATIONS; BIOTRANSFORMATION; CYTOCHROME P450; ELECTRON TRANSFER; INDUSTRIAL CONDITIONS; NICOTINAMIDE ADENINE DINUCLEOTIDES; REDOX PARTNERS; TECHNICAL IMPLEMENTATION;

BIOTECHNOLOGY;

ARTEMISININ; CYTOCHROME P450; HEME; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

BIOTECHNOLOGY; BIOTRANSFORMATION; CATALYSIS; CATALYST; CYTOCHROME; ENZYME ACTIVITY; PHOSPHATE; PROTEIN;

ALCOHOL OXIDATION; BIOCATALYST; CHEMICAL BOND; DEALKYLATION; ELECTROCHEMICAL ANALYSIS; ELECTRON TRANSPORT; ENZYME MECHANISM; HUMAN; HYDROXYLATION; NONHUMAN; SHORT SURVEY; BIOTECHNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; PROCEDURES;

BIOTECHNOLOGY; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON TRANSPORT; NADP; OXIDATION-REDUCTION;

EID: 84903598617     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-5767-7     Document Type: Short Survey

References (215)

1. Abokitse K, Hummel W (2003) Cloning, sequence analysis, and heterologous expression of the gene encoding a (S)-specific alcohol dehydrogenase from Rhodococcus erythropolis DSM 43297. Appl Microbiol Biotechnol 62:380386
2. Ahmed F, Al-Mutairi EH, Avery KL, Cullis PM, Primrose WU, Roberts GCK, Willis CL (1999) An unusual matrix of stereocomplementarity in the hydroxylation of monohydroxy fatty acids catalysed by cytochrome P-450 from Bacillus megaterium with potential application in biotransformations. Chem Commun (Camb):2049-2050 (Pubitemid 29497534)
3. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G (2010) Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330:70-74
4. Andreadeli A, Platis D, Tishkov V, Popov V, Labrou NE (2008) Structure-guided alteration of coenzyme specificity of formate dehydrogenase by saturationmutagenesis to enable efficient utilization of NADP+. FEBS J 275:3859-3869 (Pubitemid 351990951)
5. Arai M, Serizawa N, Terahara A, Tsujita Y, Tanaka M, Masuda H, Ishikawa S (1988) Pravastatin sodium (CS-514), a novel cholesterol-lowering agent which inhibits HMG-CoA reductase. Sankyo Kenkyusyo Nenpo 40:1-38
6. Ba L, Li P, Zhang H, Duan Y, Lin Z (2013) Semi-rational engineering of cytochrome P450sca-2 in a hybrid system for enhanced catalytic activity: insights into the important role of electron transfer. Biotechnol Bioeng 110:2815-2825
7. Barry SM, Kers JA, Johnson EG, Song L, Aston PR, Patel B, Krasnoff SB, Crane BR, Gibson DM, Loria R, Challis GL (2012) Cytochrome P450-catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis. Nat Chem Biol 8:814-816
8. Beckert V, Dettmer R, Bernhardt R (1994) Mutations of tyrosine 82 in bovine adrenodoxin that affect binding to cytochromes P45011A1 and P45011B1 but not electron transfer. J Biol Chem 269:2568-2573 (Pubitemid 24235751)
9. Bell SG, Dale A, Rees NH, Wong LL (2010a) A cytochrome P450 class I electron transfer system from Novosphingobium aromaticivorans. Appl Microbiol Biotechnol 86:163-175
10. Bell SG, Xu F, Johnson EO, Forward IM, Bartlam M, Rao Z, Wong LL (2010b) Protein recognition in ferredoxin-P450 electron transfer in the class I CYP199A2 system from Rhodopseudomonas palustris. J Biol Inorg Chem 15:315-328
11. Bell SG, McMillan JH, Yorke JA, Kavanagh E, Johnson EO, Wong LL (2012) Tailoring an alien ferredoxin to support native-like P450 monooxygenase activity. Chem Commun (Camb) 48:11692-11694
12. Bell SG, French L, Rees NH, Cheng SS, Preston G, Wong LL (2013) A phthalate family oxygenase reductase supports terpene alcohol oxidation by CYP238A1 from Pseudomonas putida KT2440. Biotechnol Appl Biochem 60:9-17
13. Berg A, Ingelman-Sundberg M, Gustafsson JA (1979) Purification and characterization of cytochrome P-450meg. J Biol Chem 254:5264-5271
14. Bernhardt R (1996) Cytochrome P450: structure, function, and generation of reactive oxygen species. Rev Physiol Biochem Pharmacol 127:137-221
15. Bernhardt R (2000) The role of adrenodoxin in adrenal steroidogenesis. Curr Opin Endocrinol Diabetes 7:109-115
16. Bernhardt R (2004) Cytochrome P-450. In: Lennarz WJ, Lane MD (eds) Encyclopedia of biological chemistry, edn. Elsevier, New York, pp 544-549
17. Bernhardt R (2006) Cytochromes P450 as versatile biocatalysts. J Biotechnol 124:128-145
18. Bernhardt R (2013) Cytochrome P450. In: Lennarz WJ, Lane MD (eds) The encyclopedia of biological chemistry, edn. Academic Press, Waltham, pp 607-612
19. Bernhardt R, Waterman MR (2007) Cytochrome P450 and steroid hormone biosynthesis. In: Sigel A, Sigel H, Sigel RKO (eds) The ubiquitous roles of cytochrome P450 proteins, edn. Wiley, Chichester, pp 361-369
20. Bleif S, Hannemann F, Lisurek M, von Kries JP, Zapp J, Dietzen M, Antes I, Bernhardt R (2011) Identification of CYP106A2 as a regioselective allylic bacterial diterpene hydroxylase. Chembiochem 12:576-582
21. Bleif S, Hannemann F, Zapp J, Hartmann D, Jauch J, Bernhardt R (2012) A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-beta-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl Microbiol Biotechnol 93:1135-1146
22. Boerma JS, Vermeulen NP, Commandeur JN (2011) Application of CYP102A1M11H as a tool for the generation of protein adducts of reactive drug metabolites. Chem Res Toxicol 24:1263-1274
23. Brill E, Hannemann F, Zapp J, Bruning G, Jauch J, Bernhardt R (2013) A new cytochrome P450 system from Bacillus megaterium DSM319 for the hydroxylation of 11-keto-beta-boswellic acid (KBA). Appl Microbiol Biotechnol 25. doi:10.1007/s00253-00013-05029-00250
24. Cao PR, Bernhardt R (1999) Modulation of aldosterone biosynthesis by adrenodoxin mutants with different electron transport efficiencies. Eur J Biochem 265:152-159
25. Cao PR, Bulow H, Dumas B, Bernhardt R (2000) Construction and characterization of a catalytic fusion protein system: P-450(11beta)-adrenodoxin reductase-adrenodoxin. Biochim Biophys Acta 1476:253-264 (Pubitemid 30089190)
26. Carballeira JD, Quezada MA, Hoyos P, Simeo Y, Hernaiz MJ, Alcantara AR, Sinisterra JV (2009) Microbial cells as catalysts for stereoselective red-ox reactions. Biotechnol Adv 27:686-714
27. Chen CH, Hu HY, Cho YC, Hsu WH (2006) Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin. Curr Microbiol 53:108-112 (Pubitemid 44165837)
28. Chun YJ, Shimada T, Waterman MR, Guengerich FP (2006) Understanding electron transport systems of Streptomyces cytochrome P450. Biochem Soc Trans 34:1183-1185 (Pubitemid 46769017)
29. Chun YJ, Shimada T, Sanchez-Ponce R, Martin MV, Lei L, Zhao B, Kelly SL, Waterman MR, Lamb DC, Guengerich FP (2007) Electron transport pathway for a Streptomyces cytochrome P450: cytochrome P450 105D5-catalyzed fatty acid hydroxylation in Streptomyces coelicolor A3(2). J Biol Chem 282:17486-17500 (Pubitemid 47100286)
30. Cirino PC, Arnold FH (2003) A self-sufficient peroxide-driven hydroxylation biocatalyst. Angew Chem Int Ed Engl 42:3299-3301 (Pubitemid 36917182)
31. Cirino PC, Tang Y, Takahashi K, Tirrell DA, Arnold FH (2003) Global incorporation of norleucine in place of methionine in cytochrome P450 BM-3 heme domain increases peroxygenase activity. Biotechnol Bioeng 83:729-734 (Pubitemid 36998972)
32. Coelho PS, Brustad EM, Kannan A, Arnold FH (2013a) Olefin cyclopropanation via carbene transfer catalyzed by engineered cytochrome P450 enzymes. Science 339:307-310
33. Coelho PS, Wang ZJ, Ener ME, Baril SA, Kannan A, Arnold FH, Brustad EM (2013b) A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo. Nat Chem Biol 9:485-487
34. Cornelissen S, Julsing MK, Volmer J, Riechert O, Schmid A, Buhler B (2013) Whole-cell-based CYP153A6-catalyzed (S)-limonene hydroxylation efficiency depends on host background and profits from monoterpene uptake via AlkL. Biotechnol Bioeng 110:1282-1292
35. De Mot R, Parret AH (2002) A novel class of self-sufficient cytochrome P450 monooxygenases in prokaryotes. Trends Microbiol 10:502-508 (Pubitemid 35284796)
36. Denisov IG, Sligar SG (2011) Cytochromes P450 in nanodiscs. Biochim Biophys Acta 1814:223-229
37. Di Nardo G, Gilardi G (2012) Optimization of the bacterial cytochrome P450BM3 systemfor the production of human drug metabolites. Int J Mol Sci 13:15901-15924
38. Dingler C, Ladner W, Krei GA, Cooper B, Hauer B (1996) Preparation of (R)-2-(4-hydroxyphenoxy) propionic acid by biotransformation. Pestic Sci 46:33-35
39. Donova MV, Egorova OV (2012) Microbial steroid transformations: current state and prospects. Appl Microbiol Biotechnol 94:1423-1447
40. Donova MV, Nikolayeva VM, Dovbnya DV, Gulevskaya SA, Suzina NE (2007) Methyl-beta-cyclodextrin alters growth, activity and cell envelope features of sterol-transforming mycobacteria. Microbiology 153:1981-1992 (Pubitemid 46952528)
41. Dragan CA, Blank LM, Bureik M (2006) Increased TCA cycle activity and reduced oxygen consumption during cytochrome P450-dependent biotransformation in fission yeast. Yeast 23:779-794 (Pubitemid 44430579)
42. Duport C, Spagnoli R, Degryse E, Pompon D (1998) Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast. Nat Biotechnol 16:186-189 (Pubitemid 28078509)
43. Estabrook RW, Shet MS, Fisher CW, Jenkins CM, Waterman MR (1996) The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain. Arch Biochem Biophys 333:308-315 (Pubitemid 26277005)
44. Ewen KM, Kleser M, Bernhardt R (2010) Adrenodoxin: the archetype of vertebrate-type [2Fe-2S] cluster ferredoxins. Biochim Biophys Acta:111-125
45. Ewen KM, Hannemann F, Iametti S, Morleo A, Bernhardt R (2011) Functional characterization of Fdx1: evidence for an evolutionary relationship between P450-type and ISC-type ferredoxins. J Mol Biol 413:940-951
46. Ewen KM, Ringle M, Bernhardt R (2012) Adrenodoxin-a versatile ferredoxin. IUBMB Life 64:506-512
47. Falck JR, Reddy YK, Haines DC, Reddy KM, Krishna UM, Graham S, Murry B, Peterson JA (2001) Practical, enantiospecific synthesis of 14,15-EET and leukotoxin B (vernolic acid). Tetrahedron Lett 42: 4131-4133 (Pubitemid 32522676)
48. Fantuzzi A, Capria E, Mak LH, Dodhia VR, Sadeghi SJ, Collins S, Somers G, Huq E, Gilardi G (2010) An electrochemicalmicrofluidic platformfor human P450 drug metabolism profiling. Anal Chem 82: 10222-10227
49. Fantuzzi A, Mak LH, Capria E, Dodhia V, Panicco P, Collins S, Gilardi G (2011) A new standardized electrochemical array for drugmetabolic profilingwith human cytochromes P450. Anal Chem83:3831-3839
50. + reductase and bovine adrenodoxin. Eur J Biochem 270:726-735
51. Fasan R, Chen MM, Crook NC, Arnold FH (2007) Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. Angew Chem Int Ed Engl 46:8414-8418 (Pubitemid 350114951)
52. Fasan R, Meharenna YT, Snow CD, Poulos TL, Arnold FH (2008) Evolutionary history of a specialized P450 propane monooxygenase. J Mol Biol 383:1069-1080
53. Ferrero VE, Andolfi L, Di Nardo G, Sadeghi SJ, Fantuzzi A, Cannistraro S, Gilardi G (2008) Protein and electrode engineering for the covalent immobilization of P450 BMP on gold. Anal Chem 80:8438-8446
54. Fleming BD, Johnson DL, Bond AM, Martin LL (2006) Recent progress in cytochrome P450 enzyme electrochemistry. Expert Opin Drug Metab Toxicol 2:581-589 (Pubitemid 46118328)
55. Forkmann G, Martens S (2001) Metabolic engineering and applications of flavonoids. Curr Opin Biotechnol 12:155-160 (Pubitemid 32247401)
56. Fujii T, Fujii Y, Machida K, Ochiai A, Ito M (2009) Efficient biotransformations using Escherichia coli with tolC acrAB mutations expressing cytochrome P450 genes. Biosci Biotechnol Biochem 73: 805-810
57. Fujishiroa T, Shoji O, Watanabe Y (2010) Non-covalent modification of the active site of cytochrome P450 for inverting the stereoselectivity of monooxygenation. Tetrahedron Lett 52:395-397
58. Fulco AJ (1991) P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu Rev Pharmacol Toxicol 31:177-203
59. Gavira C, Hofer R, Lesot A, Lambert F, Zucca J, Werck-Reichhart D (2013) Challenges and pitfalls of P450-dependent (+)-valencene bioconversion by Saccharomyces cerevisiae. Metab Eng 18:25-35
60. Gerber NC, Sligar SG(1994)Arole for Asp251 in cytochrome P-450cam oxygen activation. J Biol Chem 269:4260-4266 (Pubitemid 24237785)
61. Gillam EM (2007) Extending the capabilities of nature's most versatile catalysts: directed evolution ofmammalian xenobiotic-metabolizing P450s. Arch Biochem Biophys 464:176-186
62. Gillam EM (2008) Engineering cytochrome P450 enzymes. Chem Res Toxicol 21:220-231
63. Gillam EM, Guengerich FP (2001) Exploiting the versatility of human cytochrome P450 enzymes: the promise of blue roses from biotechnology. IUBMB Life 52:271-277 (Pubitemid 33731073)
64. Girhard M, Schuster S, Dietrich M, Durre P, Urlacher VB (2007) Cytochrome P450 monooxygenase from Clostridium acetobutylicum: a new alpha-fatty acid hydroxylase. Biochem Biophys Res Commun 362:114-119 (Pubitemid 47296300)
65. Girhard M, Machida K, Itoh M, Schmid RD, Arisawa A, Urlacher VB (2009) Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system. Microb Cell Factories 8(36):1-13
66. Girhard M, Klaus T, Khatri Y, Bernhardt R, Urlacher VB (2010) Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis. Appl Microbiol Biotechnol 87:595-607
67. Girhard M, Kunigk E, Tihovsky S, Shumyantseva VV, Urlacher VB (2013a) Light-driven biocatalysis with cytochrome P450 peroxygenases. Biotechnol Appl Biochem 60:111-118
68. Girhard M, Tieves F, Weber E, Smit MS, Urlacher VB (2013b) Cytochrome P450 reductase from Candida apicola: versatile redox partner for bacterial P450s. Appl Microbiol Biotechnol 97:1625-1635
69. Goni G, Zollner A, Lisurek M, Velazquez-Campoy A, Pinto S, Gomez-Moreno C, Hannemann F, Bernhardt R, Medina M (2009) Cyanobacterial electron carrier proteins as electron donors to CYP106A2 from Bacillus megaterium ATCC 13368. Biochim Biophys Acta 1794:1635-1642
70. Grinkova YV, Denisov IG, Sligar SG (2010) Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in Nanodiscs. Biochem Biophys Res Commun 398: 194-198
71. Grinkova YV, Denisov IG, McLean MA, Sligar SG (2013) Oxidase uncoupling in heme monooxygenases: human cytochrome P450 CYP3A4 in Nanodiscs. Biochem Biophys Res Commun 430: 1223-1227
72. Guengerich FP, Munro AW (2013) Unusual cytochrome P450 enzymes and reactions. J Biol Chem 288:17065-17073
73. Haga T, Hirakawa H, Nagamune T (2013) Fine tuning of spatial arrangement of enzymes in a PCNA-mediated multienzyme complex using a rigid poly-L-proline linker. PLoS One 8:1-11
74. Hakki T, Zearo S, Dragan CA, Bureik M, Bernhardt R (2008) Coexpression of redox partners increases the hydrocortisone (cortisol) production efficiency in CYP11B1 expressing fission yeast Schizosaccharomyces pombe. J Biotechnol 133:351-359 (Pubitemid 350299594)
75. Hannemann F, Bichet A, Ewen KM, Bernhardt R (2007) Cytochrome P450 systems - biological variations of electron transport chains. Biochim Biophys Acta 1770:330-344 (Pubitemid 46157074)
76. Hayashi K, Sugimoto H, Shinkyo R, Yamada M, Ikeda S, Ikushiro S, Kamakura M, Shiro Y, Sakaki T (2008) Structure-based design of a highly active vitamin D hydroxylase from Streptomyces griseolus CYP105A1. Biochemistry 47:11964-11972
77. Hayashi K, Yasuda K, Sugimoto H, Ikushiro S, Kamakura M, Kittaka A, Horst RL, Chen TC, Ohta M, Shiro Y, Sakaki T (2010) Three-step hydroxylation of vitamin D3 by a genetically engineered CYP105A1: enzymes and catalysis. FEBS J 277:3999-4009
78. Hirakawa H, Nagamune T (2010) Molecular assembly of P450 with ferredoxin and ferredoxin reductase by fusion to PCNA. Chembiochem 11:1517-1520
79. Hirakawa H, Kamiya N, Tanaka T, Nagamune T (2007) Intramolecular electron transfer in a cytochrome P450cam system with a sitespecific branched structure. Protein Eng Des Sel 20:453-459 (Pubitemid 47574742)
80. Hlavica P (2009) Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas. Biotechnol Adv 27:103-121
81. Hogg JA (1992) Steroids, the steroid community, and Upjohn in perspective: a profile of innovation. Steroids 57:593-616
82. Holton TA, Brugliera F, Lester DR, Tanaka Y, Hyland CD, Menting JG, Lu CY, Farcy E, Stevenson TW, Cornish EC (1993) Cloning and expression of cytochrome P450 genes controlling flower colour. Nature 366:276-279 (Pubitemid 23359712)
83. Hosobuchi M, Kurosawa K, Yoshikawa H (1993) Application of computer to monitoring and control of fermentation process: microbial conversion of ML-236B Na to pravastatin. Biotechnol Bioeng 42: 815-820 (Pubitemid 23266584)
84. Hotze M, Schroder G, Schroder J (1995) Cinnamate 4- hydroxylase from Catharanthus roseus, and a strategy for the functional expression of plant cytochrome P450 proteins as translational fusions with P450 reductase in Escherichia coli. FEBS Lett 374:345-350
85. Hrycay EG, Bandiera SM (2012) The monooxygenase, peroxidase, and peroxygenase properties of cytochrome P450. Arch Biochem Biophys 522:71-89
86. Imai Y, Matsunaga I, Kusunose E, Ichihara K (2000) Unique heme environment at the putative distal region of hydrogen peroxide-dependent fatty acid alpha-hydroxylase from Sphingomonas paucimobilis (peroxygenase P450(SPalpha). J Biochem 128:189-194
87. Iwuoha EI, Joseph S, Zhang Z, Smyth MR, Fuhr U, Ortiz deMontellano PR (1998) Drug metabolism biosensors: electrochemical reactivities of cytochrome P450camimmobilised in synthetic vesicular systems. J Pharm Biomed Anal 17:1101-1110 (Pubitemid 29023086)
88. Jackson CJ, Lamb DC, Marczylo TH, Warrilow AG, Manning NJ, Lowe DJ, Kelly DE, Kelly SL (2002) A novel sterol 14alpha-demethylase/ ferredoxin fusion protein (MCCYP51FX) from Methylococcus capsulatus represents a new class of the cytochrome P450 superfamily. J Biol Chem 277:46959-46965 (Pubitemid 36159200)
89. Janocha S, Bernhardt R (2013) Design and characterization of an efficient CYP105A1-based whole-cell biocatalyst for the conversion of resin acid diterpenoids in permeabilized Escherichia coli. Appl Microbiol Biotechnol 97:7639-7649
90. Jenkins CM, Waterman MR (1998) NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase. Biochemistry 37:6106-6113 (Pubitemid 28196767)
91. Jennewein S, Long RM, Williams RM, Croteau R (2004) Cytochrome P450 taxadiene 5alpha-hydroxylase, a mechanistically unusual monooxygenase catalyzing the first oxygenation step of taxol biosynthesis. Chem Biol 11:379-387 (Pubitemid 39403877)
92. Jensen K, Jensen PE, Moller BL (2011) Light-driven cytochrome P450 hydroxylations. ACS Chem Biol 6:533-539
93. Jensen K, Jensen PE, Moller BL (2012a) Light-driven chemical synthesis. Trends Plant Sci 17:60-63
94. Jensen K, Johnston JB, de Montellano PR, Moller BL (2012b) Photosystem I from plants as a bacterial cytochrome P450 surrogate electron donor: terminal hydroxylation of branched hydrocarbon chains. Biotechnol Lett 34:239-245
95. Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193-1231 (Pubitemid 28491953)
96. Joseph S, Rusling JF, Lvov YM, Friedberg T, Fuhr U (2003) An amperometric biosensor with human CYP3A4 as a novel drug screening tool. Biochem Pharmacol 65:1817-1826 (Pubitemid 36629506)
97. Julsing MK, Cornelissen S, Buhler B, Schmid A (2008) Heme-iron oxygenases: powerful industrial biocatalysts? Curr Opin Chem Biol 12:177-186
98. Julsing MK, Schrewe M, Cornelissen S, Hermann I, Schmid A, Buhler B (2012) Outer membrane protein AlkL boosts biocatalytic oxyfunctionalization of hydrophobic substrates in Escherichia coli. Appl Environ Microbiol 78:5724-5733
99. Jung ST, Lauchli R, Arnold FH (2011) Cytochrome P450: taming a wild type enzyme. Curr Opin Biotechnol 22:809-817
100. Kametani T, Furuyama H (1987) Synthesis of vitamin D3 and related compounds. Med Res Rev 7:147-171
101. Katsumoto Y, Fukuchi-Mizutani M, Fukui Y, Brugliera F, Holton TA, Karan M, Nakamura N, Yonekura-Sakakibara K, Togami J, Pigeaire A, Tao GQ, Nehra NS, Lu CY, Dyson BK, Tsuda S, Ashikari T, Kusumi T, Mason JG, Tanaka Y (2007) Engineering of the rose flavonoid biosynthetic pathway successfully generated blue-hued flowers accumulating delphinidin. Plant Cell Physiol 48:1589-1600 (Pubitemid 350135515)
102. Khatri Y, Girhard M, Romankiewicz A, Ringle M, Hannemann F, Urlacher VB, Hutter MC, Bernhardt R (2010a) Regioselective hydroxylation of norisoprenoids by CYP109D1 from Sorangium cellulosum So ce56. Appl Microbiol Biotechnol 88:485-495
103. Khatri Y, Hannemann F, Ewen KM, Pistorius D, Perlova O, Kagawa N, Brachmann AO, Muller R, Bernhardt R (2010b) The CYPome of Sorangium cellulosum So ce56 and identification of CYP109D1 as a new fatty acid hydroxylase. Chem Biol 17:1295-1305
104. Kitahama Y, Nakamura M, Yoshida Y, Aoyama Y (2009) The construction and characterization of self-sufficient lanosterol 14-demethylase fusion proteins consisting of yeast CYP51 and its reductase. Biol Pharm Bull 32:558-563
105. Kitazume T, Takaya N, Nakayama N, Shoun H (2000) Fusarium oxysporum fatty-acid subterminal hydroxylase (CYP505) is a membrane-bound eukaryotic counterpart of Bacillus megaterium cytochrome P450BM3. J Biol Chem 275:39734-39740 (Pubitemid 32059002)
106. Kleser M, Hannemann F, Hutter M, Zapp J, Bernhardt R (2012) CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst. J Biotechnol 157:405-412
107. Koschorreck K, von Bühler CJ, Schulz S, Urlacher VB (2012) Protein engineering of cytochrome P450 monooxygenases. In: Lutz S, Bornscheuer UT (eds) Protein engineering handbook, 1st edn. Wiley-VCH, Weinheim, pp 327-362
108. Kubo T, Peters MW, Meinhold P, Arnold FH (2006) Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450 BM-3. Chemistry (Easton) 12:1216-1220 (Pubitemid 43145167)
109. Kuehnel K, Maurer SC, Galeyeva Y, Frey W, Laschat S, Urlacher VB (2007) Hydroxylation of dodecanoic acid and (2R,4R,6R,8R)-tetramethyldecanol on a preparative scale using an NADH-dependent CYP102A1 mutant. Adv Synth Catal 349:1451-1461
110. Kumar S, Halpert JR (2005) Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts. Biochem Biophys Res Commun 338:456-464 (Pubitemid 41540590)
111. Lawson RJ, von Wachenfeldt C, Haq I, Perkins J, Munro AW (2004) Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. Biochemistry 43:12390-12409 (Pubitemid 39314702)
112. Lewis JC, Arnold FH (2009) Catalysts on demand: selective oxidations by laboratory-evolved cytochrome P450 BM3. Chimia 63: 309-312
113. Li S, Podust LM, Sherman DH (2007) Engineering and analysis of a self-sufficient biosynthetic cytochrome P450 PikC fused to the RhFRED reductase domain. J Am Chem Soc 129:12940-12941 (Pubitemid 350058327)
114. Lisurek M, Simgen B, Antes I, Bernhardt R (2008) Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation. Chembiochem 9:1439-1449
115. Luthra A, Gregory M, Grinkova YV, Denisov IG, Sligar SG (2013) Nanodiscs in the studies of membrane-bound cytochrome P450 enzymes. Methods Mol Biol 987(115-27):115-127
116. Makino T, Otomatsu T, Shindo K, Kitamura E, Sandmann G, Harada H, Misawa N (2012) Biocatalytic synthesis of flavones and hydroxyl-small molecules by recombinant Escherichia coli cells expressing the cyanobacterial CYP110E1 gene. Microb Cell Factories 11(95): 1-13
117. Makris TM, Davydov R, Denisov IG, Hoffman BM, Sligar SG (2002) Mechanistic enzymology of oxygen activation by the cytochromes P450. Drug Metab Rev 34:691-708 (Pubitemid 35424180)
118. Malca SH, Girhard M, Schuster S, Durre P, Urlacher VB (2011) Expression, purification and characterization of two Clostridium acetobutylicum flavodoxins: potential electron transfer partners for CYP152A2. Biochim Biophys Acta 1814:257-264
119. Matsunaga I, Yokotani N, Gotoh O, Kusunose E, Yamada M, Ichihara K (1997) Molecular cloning and expression of fatty acid alphahydroxylase from Sphingomonas paucimobilis. J Biol Chem 272: 23592-23596 (Pubitemid 27410930)
120. Maurer S, Urlacher V, Schulze H, Schmid RD (2003) Immobilisation of P450 BM-3 and an NADP+cofactor recycling system: towards a technical application of heme-containing monooxygenases in fine chemical synthesis. Adv Synth Catal 345:802-810 (Pubitemid 37393167)
121. Maurer SC, Kuhnel K, Kaysser LA, Eiben S, Schmid RD, Urlacher VB (2005) Catalytic hydroxylation in biphasic systems using CYP102A1 mutants. Adv Synth Catal 347:1090-1098 (Pubitemid 40840030)
122. McIntosh JA, Coelho PS, Farwell CC, Wang ZJ, Lewis JC, Brown TR, Arnold FH (2013) Enantioselective intramolecular C-H amination catalyzed by engineered cytochrome P450 enzymes in vitro and in vivo. Angew Chem Int Ed Engl 52:9309-9312
123. McLean KJ, Girvan HM, Munro AW (2007) Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects. Expert Opin Drug Metab Toxicol 3:847-863 (Pubitemid 350285339)
124. Michizoe J, Ichinose H, Kamiya N, Maruyama T, Goto M (2005) Functionalization of the cytochrome P450cam monooxygenase systemin the cell-like aqueous compartments of water-in-oil emulsions. J Biosci Bioeng 99:12-17 (Pubitemid 40313140)
125. Mouri T, Michizoe J, Ichinose H, Kamiya N, Goto M (2006) A recombinant Escherichia coli whole cell biocatalyst harboring a cytochrome P450cam monooxygenase system coupled with enzymatic cofactor regeneration. Appl Microbiol Biotechnol 2:514-520 (Pubitemid 44273078)
126. Müller CA, Akkapurathu B, Winkler T, Staudt S, Hummel W, Gröger H, Schwaneberg U (2013) In vitro double oxidation of n-heptane with direct cofactor regeneration. Adv Synth Catal 355:1787-1798
127. Munro AW, Girvan HM, McLean KJ (2007) Variations on a (t)heme - novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat Prod Rep 24:585-609 (Pubitemid 46848711)
128. Nelson DR (2009) The cytochrome P450 homepage. Hum Genomics 4: 59-65
129. Nelson DR (2013) A world of cytochrome P450s. Philos Trans R Soc Lond B Biol Sci 368:1-4
130. Neunzig I, Widjaja M, Peters FT, Maurer HH, Hehn A, Bourgaud F, Bureik M (2013) Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe. Appl Biochem Biotechnol 170:1751-1766
131. Nguyen KT, Virus C, Günnewich N, Hannemann F, Bernhardt R (2012) Changing the regioselectivity of a P450 from C15 to C11 hydroxylation of progesterone. Chembiochem 13:1161-1166
132. Niraula NP, Kanth BK, Sohng JK, Oh TJ (2011) Hydrogen peroxide-mediated dealkylation of 7-ethoxycoumarin by cytochrome P450 (CYP107AJ1) from Streptomyces peucetius ATCC27952. Enzym Microb Technol 48:181-186
133. Nodate M, Kubota M, Misawa N (2006) Functional expression system for cytochrome P450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp. NCIMB 9784. Appl Microbiol Biotechnol 71:455-462 (Pubitemid 44060948)
134. Ogata J, Kanno Y, Itoh Y, Tsugawa H, Suzuki M (2005) Plant biochemistry: anthocyanin biosynthesis in roses. Nature 435:757-758 (Pubitemid 40839719)
135. Ogura H, Nishida CR, Hoch UR, Perera R, Dawson JH, Ortiz de Montellano PR (2004) EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme. Biochemistry 43:14712-14721 (Pubitemid 39524946)
136. O'Keefe DP, Harder PA (1991) Occurrence and biological function of cytochrome P450 monooxygenases in the actinomycetes. Mol Microbiol 5:2099-2105 (Pubitemid 21896242)
137. O'Keefe DP, Gibson KJ, Emptage MH, Lenstra R, Romesser JA, Litle PJ, Omer CA (1991) Ferredoxins from two sulfonylurea herbicide monooxygenase systems in Streptomyces griseolus. Biochemistry 30:447-455
138. Omura T (2013) Contribution of cytochrome P450 to the diversification of eukaryotic organisms. Biotechnol Appl Biochem 60:4-8
139. O'Reilly E, Kohler V, Flitsch SL, Turner NJ (2011) Cytochromes P450 as useful biocatalysts: addressing the limitations. Chem Commun (Camb) 47:2490-2501
140. Otey CR, Bandara G, Lalonde J, Takahashi K, Arnold FH (2006) Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Biotechnol Bioeng 93:494-499 (Pubitemid 43232175)
141. Paddon CJ, Westfall PJ, Pitera DJ, Benjamin K, Fisher K, McPhee D, Leavell MD, Tai A, Main A, Eng D, Polichuk DR, Teoh KH, Reed DW, Treynor T, Lenihan J, Fleck M, Bajad S, Dang G, Dengrove D, Diola D, Dorin G, Ellens KW, Fickes S, Galazzo J, Gaucher SP, Geistlinger T, Henry R, Hepp M, Horning T, Iqbal T, Jiang H, Kizer L, Lieu B, Melis D, Moss N, Regentin R, Secrest S, Tsuruta H, Vazquez R, Westblade LF, Xu L, Yu M, Zhang Y, Zhao L, Lievense J, Covello PS, Keasling JD, Reiling KK, Renninger NS, Newman JD (2013) High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496:528-532
142. Panicco P, Dodhia VR, Fantuzzi A, Gilardi G (2011) Enzyme-based amperometric platform to determine the polymorphic response in drug metabolism by cytochromes P450. Anal Chem 83:2179-2186
143. Park JW, Lee JK, Kwon TJ, Yi DH, Kim YJ, Moon SH, Suh HH, Kang SM, Park YI (2003) Bioconversion of compactin into pravastatin by Streptomyces sp. Biotechnol Lett 25:1827-1831
144. Peng Y, Yashphe J, Demain AL (1997) Biotransformation of compactin to pravastatin by Actinomadura sp. 2966. J Antibiot (Tokyo) 50: 1032-1035 (Pubitemid 28045936)
145. Peterson DH, Murray HC, Eppstein SH, Reineke LM, Weintraub A, Meister PD, Leigh HM (1952) Microbiological transformations of steroids.1. Introduction of oxygen at carbon-11 of progesterone. J Am Chem Soc 74:5933-5936
146. Peterson JA, Sevrioukova I, Truan G, Graham-Lorence SE (1997) P450BM-3; a tale of two domains - or is it three? Steroids 62: 117-123 (Pubitemid 27066994)
147. Petzoldt K, Annen K, Laurent H, Wiechert R (1982) Process for the preparation of 11-beta-hydroxy steroids. US Patent, Schering Aktiengesellschaft (Berlin, Germany)
148. Podust LM, Sherman DH (2012) Diversity of P450 enzymes in the biosynthesis of natural products. Nat Prod Rep 29:1251-1266
149. Prosser DE, Jones G (2004) Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29:664-673 (Pubitemid 39491265)
150. Reinen J, van Leeuwen JS, Li Y, Sun L, Grootenhuis PD, Decker CJ, Saunders J, Vermeulen NP, Commandeur JN (2011) Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space. Drug Metab Dispos 39:1568-1576
151. Rentmeister A, Arnold FH, Fasan R (2009) Chemo-enzymatic fluorination of unactivated organic compounds. Nat Chem Biol 5:26-28
152. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, Keasling JD (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440:940-943
153. Roberts GA, Grogan G, Greter A, Flitsch SL, Turner NJ (2002) Identification of a new class of cytochrome P450 from a Rhodococcus sp. J Bacteriol 184:3898-3908 (Pubitemid 34705447)
154. Rua F, Sadeghi SJ, Castrignano S, Di Nardo G, Gilardi G (2012) Engineering Macaca fascicularis cytochrome P450 2C20 to reduce animal testing for new drugs. J Inorg Biochem 117:277-284
155. Ruijssenaars HJ, Sperling EM, Wiegerinck PH, Brands FT, Wery J, de Bont JA (2007) Testosterone 15beta-hydroxylation by solvent tolerant Pseudomonas putida S12. J Biotechnol 131:205-208 (Pubitemid 47187514)
156. Rylott EL, Jackson RG, Edwards J, Womack GL, Seth-Smith HM, Rathbone DA,
157. Sabbadin F, Hyde R, Robin A, Hilgarth EM, Delenne M, Flitsch S, Turner N, Grogan G, Bruce NC (2010) LICRED: a versatile dropin vector for rapid generation of redox-self-sufficient cytochrome P450s. Chembiochem 11:987-994
158. Sadeghi SJ, Gilardi G (2013) Chimeric P450 enzymes: activity of artificial redox fusions driven by different reductases for biotechnological applications. Biotechnol Appl Biochem 60:102-110
159. Sadeghi SJ, Meharenna YT, Fantuzzi A, Valetti F, Gilardi G (2000) Engineering artificial redox chains by molecular 'Lego'. Faraday Discuss:135-153; discussion 171-190
160. Sadeghi SJ, Fantuzzi A, Gilardi G (2011) Breakthrough in P450 bioelectrochemistry and future perspectives. Biochim Biophys Acta 1814:237-248
161. Sadeghi SJ, Ferrero S, Di Nardo G, Gilardi G (2012) Drug-drug interactions and cooperative effects detected in electrochemically driven human cytochrome P450 3A4. Bioelectrochemistry 86:87-91
162. Sakaki T, Sugimoto H, Hayashi K, Yasuda K, Munetsuna E, Kamakura M, Ikushiro S, Shiro Y (2011) Bioconversion of vitamin D to its active form by bacterial or mammalian cytochrome P450. Biochim Biophys Acta 1814:249-256
163. Salazar O, Cirino PC, Arnold FH (2003) Thermostabilization of a cytochrome P450 peroxygenase. Chembiochem 4:891-893 (Pubitemid 37185702)
164. Sasaki J, Mikami A, Mizoue K, Omura S (1991) Transformation of 25-and 1 alpha-hydroxyvitamin D3 to 1 alpha, 25-dihydroxyvitamin D3 by using Streptomyces sp. strains. Appl Environ Microbiol 57: 2841-2846
165. Sasaki J, Miyazaki A, Saito M, Adachi T, Mizoue K, Hanada K, Omura S (1992) Transformation of vitamin D3 to 1 alpha,25-dihydroxyvitamin D3 via 25-hydroxyvitamin D3 using Amycolata sp. strains. Appl Microbiol Biotechnol 38:152-157
166. Sawada N, Sakaki T, Yoneda S, Kusudo T, Shinkyo R, Ohta M, Inouye K (2004) Conversion of vitamin D3 to 1 alpha,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1. Biochem Biophys Res Commun 320:156-164 (Pubitemid 38781796)
167. Sawayama AM, Chen MM, Kulanthaivel P, Kuo MS, Hemmerle H, Arnold FH (2009) A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. Chemistry (Easton) 15:11723-11729
168. Scheps D, Honda Malca S, Richter SM, Marisch K, Nestl BM, Hauer B (2011) Synthesis of omega-hydroxy dodecanoic acid based on an engineered CYP153A fusion construct. Microb Biotechnol 6:694-707
169. Schewe H, Kaup BA, Schrader J (2008) Improvement of P450(BM-3) whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli. Appl Microbiol Biotechnol 78:55-65
170. Schewe H, Holtmann D, Schrader J (2009) P450(BM-3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system. Appl Microbiol Biotechnol 83:849-857
171. Schiffler B, Bernhardt R (2003) Bacterial (CYP101) and mitochondrial P450 systems-how comparable are they? Biochem Biophys Res Commun 312:223-228 (Pubitemid 37443950)
172. Schiffler B, Kiefer M, Wilken A, Hannemann F, Adolph HW, Bernhardt R (2001) The interaction of bovine adrenodoxin with CYP11A1 (cytochrome P450scc) and CYP11B1 (cytochrome P45011beta). Acceleration of reduction and substrate conversion by site-directed mutagenesis of adrenodoxin. J Biol Chem 276:36225-36232
173. Schneider E, Clark DS (2012) Cytochrome P450 (CYP) enzymes and the development of CYP biosensors. Biosens Bioelectron 39:1-13
174. Schroer K, Kittelmann M, Lutz S (2010) Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis. Biotechnol Bioeng 106:699-706
175. Schuckel J, Rylott EL, Grogan G, Bruce NC (2012) A gene-fusion approach to enabling plant cytochromes P450 for biocatalysis. Chembiochem 13:2758-2763
176. Serizawa N (2000) Biocatalytic production of pravastatin, an anticholesterol drug. In: Patel RN (ed) Stereoselective biocatalysis, edn. Marcel Dekker, New York-Basel, pp 703-710
177. Serizawa N, Matsuoka T (1991) A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochim Biophys Acta 1084:35-40
178. Sevrioukova IF, Peterson JA (1995) NADPH-P450 reductase: structural and functional comparisons of the eukaryotic and prokaryotic isoforms. Biochimie 77:562-572
179. Shoji O, Fujishiro T, Nakajima H, Kim M, Nagano S, Shiro Y, Watanabe Y (2007) Hydrogen peroxide dependent monooxygenations by tricking the substrate recognition of cytochrome P450BSbeta. Angew Chem Int Ed Engl 46:3656-3659 (Pubitemid 46981241)
180. Shumyantseva VV, Bulko TV, Archakov AI (2005) Electrochemical reduction of cytochrome P450 as an approach to the construction of biosensors and bioreactors. J Inorg Biochem 99:1051-1063
181. Shumyantseva VV, Bulko TV, Kuznetsova GP, Samenkova NF, Archakov AI (2009) Electrochemistry of cytochromes P450: analysis of current-voltage characteristics of electrodes with immobilized cytochromes P450 for the screening of substrates and inhibitors. Biochemistry (Mosc) 74:438-444
182. Sibbesen O, De Voss JJ, Montellano PR (1996) Putidaredoxin reductase-putidaredoxin- cytochrome P450cam triple fusion protein. Construction of a self-sufficient Escherichia coli catalytic system. J Biol Chem 271:22462-22469 (Pubitemid 26304682)
183. Siriphongphaew A, Pisnupong P, Wongkongkatep J, Inprakhon P, Vangnai AS, Honda K, Ohtake H, Kato J, Ogawa J, Shimizu S, Urlacher VB, Schmid RD, Pongtharangkul T (2012) Development of a whole-cell biocatalyst co-expressing P450 monooxygenase and glucose dehydrogenase for synthesis of epoxyhexane. Appl Microbiol Biotechnol 95:357-367
184. Sono M, Roach MP, Coulter ED, Dawson JH (1996) Heme-containing oxygenases. Chem Rev 96:2841-2888
185. Staudt S, Burda E, Giese C, Müller CA, Marienhagen J, Schwaneberg U, Hummel W, Drauz K, Gröger H (2013) Direct oxidation of cycloalkanes to cycloalkanones with oxygen in water. Angew Chem Int Ed 52:2359-2363
186. Sugimoto H, Shinkyo R, Hayashi K, Yoneda S, Yamada M, Kamakura M, Ikushiro S, Shiro Y, Sakaki T (2008) Crystal structure of CYP105A1 (P450SU-1) in complex with 1alpha,25-dihydroxyvitamin D3. Biochemistry 47:4017-4027 (Pubitemid 351458116)
187. Sundermann A, Oostenbrink C (2013) Molecular dynamics simulations give insight into the conformational change, complex formation, and electron transfer pathway for cytochrome P450 reductase. Protein Sci 22:1183-1195
188. Szczebara FM, Chandelier C, Villeret C, Masurel A, Bourot S, Duport C, Blanchard S, Groisillier A, Testet E, Costaglioli P, Cauet G, Degryse E, Balbuena D, Winter J, Achstetter T, Spagnoli R, Pompon D, Dumas B (2003) Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat Biotechnol 21: 143-149 (Pubitemid 36188212)
189. Teoh KH, Polichuk DR, Reed DW, Covello PS (2009)Molecular cloning of an aldehyde dehydrogenase implicated in artemisinin biosynthesis in Artemisia annua. Botany-Botanique 87:635-642
190. Theurer M, El Baz Y, Koschorreck K, Urlacher VB, Rauhut G, Baro A, Laschat S (2011) Chemoenzymatic synthesis of the C3-C11-fragment of borrelidin. Eur J Org Chem:4241-4249
191. Uhlmann H, Kraft R, Bernhardt R (1994) C-terminal region of adrenodoxin affects its structural integrity and determines differences in its electron transfer function to cytochrome P-450. J Biol Chem 269:22557-22564 (Pubitemid 24273360)
192. Urlacher VB (2010) Catalysis with Cytochrome P450 Monooxygenases. In: Anastas PT, Crabtree RH (eds) Handbook of green chemistry, pp 1-25
193. Urlacher VB, Eiben S (2006) Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol 24:324-330 (Pubitemid 43975576)
194. van Beilen JB, Funhoff EG, van Loon A, Just A, Kaysser L, Bouza M, Holtackers R, Rothlisberger M, Li Z, Witholt B (2006) Cytochrome P450 alkane hydroxylases of the CYP153 family are common in alkane-degrading eubacteria lacking integral membrane alkane hydroxylases. Appl Environ Microbiol 72:59-65
195. van den Bemd GJ, Chang GT (2002) Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets 3:85-94 (Pubitemid 34296306)
196. Venkateswarlu K, Kelly DE, Kelly SL (1997) Characterization of Saccharomyces cerevisiae CYP51 and a CYP51 fusion protein with NADPH cytochrome P-450 oxidoreductase expressed in Escherichia coli. Antimicrob Agents Chemother 41:776-780 (Pubitemid 27150530)
197. Verma R, Schwaneberg U, Roccatano D (2014) Insight into the redox partner interaction mechanism in cytochrome P450BM-3 using molecular dynamics simulations. Biopolymers 101:197-209
198. Virus C, Bernhardt R (2008) Molecular evolution of a steroid hydroxylating cytochrome P450 using a versatile steroid detection system for screening. Lipids 43:1133-1141
199. von Buhler C, Le-Huu P, Urlacher VB (2013) Cluster screening: an effective approach for probing the substrate space of uncharacterized cytochrome P450s. Chembiochem 14:2189-2198
200. Vottero E, Rea V, Lastdrager J, Honing M, Vermeulen NP, Commandeur JN (2011) Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11. J Biol Inorg Chem 16:899-912
201. Watanabe I, Serizawa N (1998) Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome P450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital. Gene 210:109-116 (Pubitemid 28156393)
202. Watanabe I, Nara F, Serizawa N (1995) Cloning, characterization and expression of the gene encoding cytochrome P-450sca-2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor. Gene 163:81-85
203. Weber E, Seifert A, Antonovici M, Geinitz C, Pleiss J, Urlacher VB (2010) Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. Chem Commun (Camb) 47:944-946
204. Weckbecker A, Hummel W (2006) Cloning, expression, and characterization of an (R)-specific alcohol dehydrogenase from Lactobacillus kefir. Biocatalysis Biotransformation 24:380-389 (Pubitemid 44615050)
205. Weis R, Winkler M, Schittmayer M, Kambourakis S, Vink M, Rozzell JD, Glieder A (2009) A diversified library of bacterial and fungal bifunctional cytochrome P450 enzymes for drug metabolite synthesis. Adv Synth Catal 351:2140-2146
206. Weiss A (2007) Selective microbail oxidations in industry: oxidations of alkanes, fatty acids, heterocyclic compounds, aromatic compounds and glycerol using native or recombinant micro-organisms. In: Schmid RD, Urlacher VB (eds) Modern oxidation: enzymes, reactions and applications, edn. Wiley-VCH, Weinheim, pp 193-210
207. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, Fickes S, Diola D, Benjamin KR, Keasling JD, Leavell MD, McPhee DJ, Renninger NS, Newman JD, Paddon CJ (2012) Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 109:E111-E118
208. Whitehouse CJ, Bell SG, Wong LL (2012) P450(BM3) (CYP102A1): connecting the dots. Chem Soc Rev 41:1218-1260
209. WHO (2006) Guidelines for the treatment of malaria. World Health Organization, Geneva
210. WHO (2010) Guidelines for the treatment of malaria. World Health Organization, Geneva
211. Wichmann R, Vasic-Racki D (2005) Cofactor regeneration at the lab scale. Adv Biochem Eng Biotechnol 92:225-260 (Pubitemid 44617160)
212. Yang W, Bell SG, Wang H, Zhou W, Hoskins N, Dale A, Bartlam M, Wong LL, Rao Z (2010)Molecular characterization of a class I P450 electron transfer system from Novosphingobium aromaticivorans DSM12444. J Biol Chem 285:27372-27384
213. Zehentgruber D, Hannemann F, Bleif S, Bernhardt R, Lutz S (2010) Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2. Chembiochem 11:713-721
214. Zollner A, Nogues I, Heinz A, Medina M, Gomez-Moreno C, Bernhardt R (2004) Analysis of the interaction of a hybrid system consisting of bovine adrenodoxin reductase and flavodoxin from the cyanobacterium Anabaena PCC 7119. Bioelectrochemistry 63:61-65 (Pubitemid 38534196)
215. Zollner A, Buchheit D, Meyer MR, Maurer HH, Peters FT, Bureik M (2010) Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes. Bioanalysis 2:1277-1290